Opioid Use Linked to Lower Quality of Life in Older Australians

A secondary cross-sectional analysis of baseline data from the STAtins in Reducing Events in Elderly (STAREE) trial examined prescription opioid use and health-related quality of life among community-dwelling older Australians. The study, published in the Journal of the American Geriatrics Society, included 479 self-reported opioid users and 9,492 non-users. Quality of life was assessed using the 36-item Short Form Survey, with regression models progressively adjusting for sociodemographic, clinical and psychosocial factors.

Opioid users had lower mean quality-of-life scores in unadjusted analyses (β = −14.30; 95% CI, −15.59 to −13.02). The association was attenuated but remained statistically significant after full adjustment (β = −7.58; 95% CI, −8.80 to −6.35). Lower scores were reported across all assessed domains, including physical and social functioning, vitality, pain and mental health. The largest differences were in physical functioning, approximately 20–25 points lower among opioid users.

The findings support attention to quality of life, functional status and psychosocial factors when reviewing older patients taking opioids. However, the cross-sectional design cannot determine whether opioid use contributes to poorer quality of life or reflects underlying illness and pain. Opioid exposure was self-reported, and full-text details were unavailable for this assessment.